|
Status |
Public on Feb 19, 2018 |
Title |
MFE 296 parental 4 |
Sample type |
RNA |
|
|
Source name |
MFE-296 parental cell line
|
Organism |
Homo sapiens |
Characteristics |
cell line: MFE-296 cell type: endometrial cancer cell line parental cell type: endometrial cancer cell line
|
Extracted molecule |
total RNA |
Extraction protocol |
Qiagen RNeasy Micro kit.
|
Label |
biotin
|
Label protocol |
100 ng of total RNA was reverse transcribed and biotin labeled.
|
|
|
Hybridization protocol |
Standard Illumina hybridization protocol.
|
Scan protocol |
Standard Illumina scanning protocol.
|
Description |
Parental cell line. Replicate 4
|
Data processing |
The data were normalised using quantile normalisation with GenomeStudio.
|
|
|
Submission date |
May 05, 2016 |
Last update date |
Feb 19, 2018 |
Contact name |
Jun Wang |
E-mail(s) |
j.a.wang@qmul.ac.uk
|
Organization name |
Barts Cancer Institute, Queen Mary, London
|
Street address |
Charterhouse Square
|
City |
London |
ZIP/Postal code |
EC1M 6BQ |
Country |
United Kingdom |
|
|
Platform ID |
GPL10558 |
Series (1) |
GSE81169 |
PHLDA1 mediates drug resistance in receptor tyrosine kinase driven cancer |
|